Clinical trial · Observational
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer: A Multicenter Study
NCT06733766CI-TRIAL-00086044recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for recurrent thyroid cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Recurrent Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ultrasound-guided thermal ablation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- ultrasound-guided thermal ablation
- description
- ultrasound-guided thermal ablation
- interventionNames
- Procedure: ultrasound-guided thermal ablation
Primary outcomes (1)
- measure
- rate of disease progression
- timeFrame
- through study completion, an average of 6 months
- description
- cervical lymph node metastases and persistent tumors confirmed by pathology, Distant metastasis detected by CT, positron emission tomography, or bone scan if there were suspicious symptoms.
Secondary outcomes (5)
- measure
- rate of complications
- timeFrame
- 1 week
- description
- complication of ablation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. patient received thyroidectomy for thyroid cancer 2. recurrent lesions were pathologically proven to be malignant by core-needle biopsy or fine needle aspiration 3. no evidence of distant metastases. 4. follow-up period ≥12 months Exclusion Criteria: 1. coagulation disorder, serious heart, respiratory, liver, or renal failure 2. dysfunction of the vocal cord on the opposite side
References
Publications (0)
Data not yet available
No reference posted for this study.